COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,893 Articles (22,568 medRxiv, 8,325 bioRxiv)

Most recent first Previous |  Page 1163: Articles 11621-11630  | Next

Time trends in social contacts before and during the COVID-19 pandemic: the CONNECT study
Drolet, M., Godbout, A., Mondor, M., Drolet-Roy, L., Beraud, G., Lemmieux-Mellouki, P., Demers, E., Boily, M.-C., Sauvageau, C., De Serres, G., Hens, N., Beutels, P., Dervaux, B., Brisson, M.
10.1101/2021.10.06.21264632 — Posted: 2021-10-07
Characterizing the spatiotemporal heterogeneity of the COVID-19 vaccination landscape
Tiu, A., Susswein, Z., Merritt, A., Bansal, S.
10.1101/2021.10.04.21263345 — Posted: 2021-10-07
Transmission of SARS-CoV-2 in Norwegian schools: A population-wide register-based cohort study on characteristics of the index case and secondary attack rates
Rotevatn, T. A., Larsen, V. B., Johansen, T. B., Astrup, E., Suren, P., Greve-Isdahl, M., Telle, K. E.
10.1101/2021.10.04.21264496 — Posted: 2021-10-07 Discussion: Onsite
Sero Prevalence of COVID-19 in Palestine in 2020
Rayan, I., Qaddomi, S. E., Najjar, O., Abbas, S., Mousa, K., Al Ariqi, L., Aly, E. A., Abu Khader, K., Barakat, A., Salman, R.
10.1101/2021.10.04.21263131 — Posted: 2021-10-07
Safety and Immunogenicity of CoronaVac and ChAdOx1 Against the SARS-CoV-2 Circulating Variants of Concern (Alpha, Delta, Beta) in Thai Healthcare Workers
Angkasekwinai, N., Sewatanon, J., Niyomnaitham, S., Phumiamorn, S., Sukapirom, K., Sapsutthipas, S., Sirijatuphat, R., Wittawatmongkol, O., Senawong, S., Mahasirimongkol, S., Trisiriwanich, S., Chokephaibulkit, K.
10.1101/2021.10.03.21264451 — Posted: 2021-10-07
Poking COVID-19: insights on genomic constraints among immune-related genes between Qatari and Italian populations
Mbarek, H., Cocca, M., Al-Sarraj, Y., Saad, C., Mezzavilla, M., Al-Muftah, W., Cocciadiferro, D., Novelli, A., Quinti, I., AlTawashi, A., Salvaggio, S., Althani, A., Ismail, S. I.
10.1101/2021.10.04.21264507 — Posted: 2021-10-07
Assessment of Post COVID-19 Health Problems and its Determinants in North India: A descriptive cross section study
Senjam, S. S., Yatan Pal Singh, B., Parmeshwar, K., Nichal, N., Manna, S., Madan, K., Ahmed, N. H., Gupta, N., Sharma, R., Gupta, Y., Ray, A., Gupta, V., Vashist, P., Kumar, A., Dar, L., Singh Titiyal, J., Tandon, R., Gulleira, R.
10.1101/2021.10.03.21264490 — Posted: 2021-10-07
SARS-CoV-2 RNA and antibody dynamics in a Dutch household study with dense sampling frame
Han, W. G. H., Swart, A., Bonacic Marinovic, A., Eggink, D., Reimerink, J., Wijsman, L. A., van der Veer, B., van den Brink, S., van den Brandt, A.-M., Brouwer, F., Hoogerwerf, M., the Dutch FFX-COVID-19 research group, , Reukers, D. F. M., Rots, N., Reusken, C., Meijer, A.
10.1101/2021.10.06.21263384 — Posted: 2021-10-06
SARS-CoV-2 hijacks neutralizing dimeric IgA for enhanced nasal infection and injury
Zhou, B., Zhou, R., Chan, J. F.-W., Zeng, J., Zhang, Q., Yuan, S., Liu, L., Robinot, R., Shan, S., Ge, J., Kwong, H. Y.-H., Zhou, D., Xu, H., Chan, C. C.-S., Poon, V. K.-M., Chu, H., Yue, M., Kwan, K.-Y., Chan, C.-Y., Liu, N., Chan, C. C.-Y., Chik, K. K.-H., Du, Z., Au, K.-K., Huang, H., Man, H.-O., Cao, J., Li, C., Wang, Z., Zhou, J., Song, Y., Yeung, M.-L., To, K. K.-W., Ho, D. D., Chakrabarti, L. A., Wang, X., Zhang, L., Yuen, K.-Y., Chen, Z.
10.1101/2021.10.05.463282 — Posted: 2021-10-06
SARS-CoV-2 PLpro whole human proteome cleavage prediction and enrichment/depletion analysis
Prescott, L.
10.1101/2021.10.04.462902 — Posted: 2021-10-06

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).